TAK News and Press, Takeda Pharmaceutical Company Limited American Depositary Shares From 04/13/23

2023-04-13 05:02:47 ET A federal appeals court blocked part of a Texas court's ruling that would halt the access to the abortion pill mifepristone. Earlier this week, the U.S. Justice Department (DOJ) had asked the U.S. 5th Circuit Court of Appeals to halt U.S. Judge Matthew Kacsmar...

2023-04-12 10:50:20 ET Summary CSL Limited is one of the largest global biotechnology companies globally that specializes in the research, development, and manufacturing of plasma-based therapies, vaccines, and other pharmaceutical products. The combination of long-term revenue re...

HYQVIA ® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] , the Only Once-a-Month – Every Three or Four Weeks – Subcutaneous Immunoglobulin (ScIG), is Now Approved for People Two Years of Age and Older with Primary Immunodeficiency ...

The global market access and expansion partnership, initially established in 2015, aims to provide an efficient and timely diagnosis to patients with Lysosomal Storage Disorders (LSDs) Diagnosis plays a critical role in guiding patients towards appropriate and readily available therapies ...

2023-04-10 00:38:00 ET Summary Duality Biologics (Suzhou) out-licensed global rights (ex-China) for two ADC candidates to BioNTech in a deal worth $170 million upfront and up to $1.5 billion in milestone payments. Shanghai HutchMed has completed the rolling submission of a US NDA ...

Takeda Pharmaceutical Company Limited (NYSE: TAK) has caught the attention of the investment community today with its bullish price action. The company's shares are currently up 2.78% on the day to $17. Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, ...

2023-04-03 11:28:47 ET Summary Today, we put a small biotech company called Puma Biotechnology, Inc. in the spotlight. The stock appears cheap on a price to sales basis, but the company had been dogged by a lawsuit and some other issues. Is Puma a buy at just over three bucks ...

FY22 Investment Brings Program Total to Nearly $40 Million, Adding 21 New Grant Partners Company Continues to Improve Equity Among Under-Resourced Communities Focusing on Areas of Health, Education, Environment and Providing First U.S. CSR Report, Takeda Cares for Communities ...

2023-04-03 04:12:14 ET Summary My portfolio, built specifically for my retirement ~20 years from now, features growth, dividends, and risk stocks for a happy retirement. Great performances by Bitcoin, AMD, and Meta propelled my portfolio to all-time highs and market-beating return...

2023-04-03 03:51:40 ET Summary Sales of Takhzyro amounted to 44.1 billion Japanese yen in the 3rd quarter of 2022, an increase of 42.7% from the previous year. Takeda Pharmaceutical's revenue was $8,354 million in Q3 2022, showing phenomenal growth both year-on-year and quarter-on...